PLEKHN1 Activators
PLEKHN1 Activators pertain to a class of chemicals that selectively increase the biological activity of the protein PLEKHN1, which is encoded by the PLEKHN1 gene. PLEKHN1 is a pleckstrin homology domain-containing protein, suggesting it has roles in cellular signaling or cytoskeletal organization. Activators are molecules that can either enhance the protein's expression or augment its activity within cellular processes. The mechanisms by which these activators function might involve direct interaction with the PLEKHN1 protein, leading to a conformational change that results in an increase in its activity or the stabilization of the protein to prolong its functional lifespan within the cell. Alternatively, activators could bind to regulatory regions on the PLEKHN1 gene itself, thereby upregulating transcription and translation to increase protein production.
In the realm of molecular biology and biochemistry, the discovery and characterization of PLEKHN1 Activators involves rigorous research methodologies. These could include high-throughput screening of compound libraries to identify molecules that result in the upregulation of PLEKHN1 activity. Once identified, such compounds would be further studied to determine their specificity, mechanism of action, and the structural basis of their interaction with the PLEKHN1 protein or gene. The comprehensive study of PLEKHN1 Activators would extend the understanding of the PLEKHN1 protein's role in cellular functions. By manipulating PLEKHN1 activity, scientists can explore its involvement in cellular signaling pathways and its interaction with other cellular components. These activators could also serve as valuable tools for probing the physiological functions of PLEKHN1 and could yield insights into the broader implications of pleckstrin homology domain-containing proteins in cell biology. Moreover, understanding how such activators work might shed light on the general principles of protein activation and gene expression regulation, contributing to foundational knowledge in the field of cellular biochemistry.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly raises intracellular cAMP levels which, through a cascade involving PKA activation, can enhance PLEKHN1 by facilitating its role in mediating inflammatory responses as PKA can phosphorylate proteins in related signaling pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentration, which can enhance signaling pathways that involve calcium-dependent proteins, thereby potentially enhancing PLEKHN1 function in immune response and inflammation pathways. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits phosphodiesterase 4, leading to an increase in cAMP levels. Elevated cAMP can activate PKA, which in turn may enhance PLEKHN1 function as PKA can phosphorylate regulatory proteins in pathways where PLEKHN1 is involved, enhancing its role in signaling. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
PGE2 operates via E-prostanoid receptors which can trigger a rise in intracellular cAMP levels. This elevation in cAMP could lead to activation of PKA, which may enhance the functional activity of PLEKHN1 by modulating signaling pathways related to inflammation that involve PLEKHN1. | ||||||
LTB4 (Leukotriene B4) | 71160-24-2 | sc-201043 | 50 µg | $374.00 | 4 | |
LTB4 acts through BLT receptors to influence inflammation signaling pathways. These pathways could enhance PLEKHN1 function, which is implicated in inflammatory responses, through activating proteins that interact with or modify PLEKHN1 activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P binds to S1P receptors that modulate a variety of signaling pathways, including those involved in inflammation. The activation of these pathways could enhance PLEKHN1 function, as PLEKHN1 is implicated in inflammatory signaling. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to increased intracellular calcium levels, activating calcium-dependent signaling pathways. Such pathways could enhance PLEKHN1 function by modulating proteins and processes in which PLEKHN1 is involved, particularly those related to inflammation and immune response. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates SIRT1 which can deacetylate proteins involved in inflammatory signaling pathways. By influencing these pathways, resveratrol could enhance PLEKHN1's function in mediating inflammatory responses, given PLEKHN1's involvement in these pathways. | ||||||
Apigenin | 520-36-5 | sc-3529 sc-3529A sc-3529B sc-3529C sc-3529D sc-3529E sc-3529F | 5 mg 100 mg 1 g 5 g 25 g 100 g 1 kg | $33.00 $214.00 $734.00 $1151.00 $2348.00 $3127.00 $5208.00 | 22 | |
Apigenin is known to inhibit NF-κB, a transcription factor that plays a critical role in inflammatory processes. By modulating NF-κB activity, apigenin could enhance PLEKHN1's function in inflammation signaling pathways, as PLEKHN1 is implicated in these pathways. | ||||||